Outsourcing Trends in the Development of Biologics
The development of biologic drugs continues to increase at a rapid pace. Growing numbers of...
Posts about
Formulations
Fill-Finish Development Challenges & Solutions for CDMOs
Recently, contract development and manufacturing organizations (CDMOs) involved in the...
Case Study: OSD Formulation Development
Client Profile
The client needed formulation development of an oral dosage form from scratch. They...
QbD Addresses API Supply in Orphan Drug Formulation
According to the Food and Drug Administration and the Orphan Drug Designation program, orphan...
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
The agreement represents another step toward the proprietary manufacturing, formulation, and...
Virtual Open House: New Sterile Fill-Finish Development & Manufacturing Facility
We're kicking off the opening of our new formulation and sterile fill-finish facility with a...
White Paper: Insight into Orphan Drug Formulations and Regulations
The US Orphan Drug Act of 1983 characterizes an orphan disease as a rare medical condition that...
Blog: Formulating for Orphan Indication Drug Products
According to the US Orphan Drug Act of 1983, a rare disease is defined as a condition that affects...
Case Study: Challenges and Solutions to Formulating an Orphan Drug
According to the Food and Drug Administration and the Orphan Drug Designation program, orphan...